NCT00919139

S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.

Study Contact:

Study Phase:

Recruitment Status:

COMPLETED

NCT ID:

NCT00919139

Principal Investigator:

Study Type:

OBSERVATIONAL

Official Title:

S0309, Myeloma Specimen Repository Protocol, Ancillary

Summary

RATIONALE: Collecting and storing samples of blood and bone marrow from patients with cancer to study in the laboratory may help doctors find better ways to ways to treat the cancer.

PURPOSE: The purpose of this study is to collect and store blood and bone marrow samples from patients with multiple myeloma, smoldering myeloma, Waldenstrom's macroglobulinemia, amyloidosis, and monoclonal gammopathy of undetermined significance to be tested in the laboratory.

Eligibility

DISEASE CHARACTERISTICS:

* Diagnosis of 1 of the following:

* Multiple myeloma
* Smoldering myeloma
* Waldenstrom's macroglobulinemia
* Amyloidosis
* Monoclonal gammopathy of undetermined significance
* Must be currently registered on a Southwest Oncology Group-coordinated treatment study (SWOG or Intergroup)
* Must have pretreatment specimens to submit to this study
* No cytogenetic samples

PATIENT CHARACTERISTICS:

* Not specified

PRIOR CONCURRENT THERAPY:

* Not specified

Disease(s) and\or Condition(s)

Multiple Myeloma

Smoldering Myeloma

Waldenstrom's Macroglobulinemia

Monoclonal Gammopathy of Undetermined Significance

Amyloidosis

Primary Purpose

Intervention/Treatment

- Type: OTHER
- Name: biologic sample preservation procedure
- Description: Blood and 3-4 cc bone marrow aspirate collected at same time (in association with treatment protocols on which patient is registered)
- Arm Group Labels:

Sponsor

SWOG Cancer Research Network